Ceramide accumulation and microbiota-derived sphingolipids: A novel axis in obesity-linked diabetic inflammation
Obesity Medicine · 2026-07 · 62 · 100723
DOI: 10.1016/j.obmed.2026.100723 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity Medicine, 2026-07. Verfasst von Saksham Saxena und 8 weiteren Autor:innen. Die Arbeit nennt 137 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Saxena, S., Ahmed, I., Jha, R. K., Swagatika, S., Kumar, N., Saxena, M., Chakrabarty, S., Choudhary, R. K., & Bhattacharjee, A. (2026). Ceramide accumulation and microbiota-derived sphingolipids: A novel axis in obesity-linked diabetic inflammation. Obesity Medicine, 62, 100723. https://doi.org/10.1016/j.obmed.2026.100723
Vancouver
Saxena S, Ahmed I, Jha RK, Swagatika S, Kumar N, Saxena M, et al. Ceramide accumulation and microbiota-derived sphingolipids: A novel axis in obesity-linked diabetic inflammation. Obesity Medicine. 2026;62:100723. doi:10.1016/j.obmed.2026.100723
BibTeX
@article{Saxena2026,
author = {Saxena, Saksham and Ahmed, Irshad and Jha, Rajeev Kumar and Swagatika, Sushree and Kumar, Naveen and Saxena, Mansi and Chakrabarty, Susmita and Choudhary, Ranjay Kumar and Bhattacharjee, Aniruddha},
title = {Ceramide accumulation and microbiota-derived sphingolipids: A novel axis in obesity-linked diabetic inflammation},
journal = {Obesity Medicine},
year = {2026},
volume = {62},
pages = {100723},
doi = {10.1016/j.obmed.2026.100723}
}
EUVIMED